-
Innovative
-
Biologics
-
Drug Name
-
Therapeutic Area
-
Type
-
Discovery
-
Preclinical
-
Phase 1
-
Phase 2
-
Phase 3
-
Submission
XENLETA® (lefamulin)
Anti-Infective
Small Molecule
1
1
1
1
1
1
Contepo™ (fosfomycin) for Injection
Anti-Infective
Small Molecule
1
1
1
1
1
1
XTMAB-16
Immunology & Inflammation
Biologic
1
1
1
1
1
1
-
Discovery
-
Preclinical
-
Phase 1
-
Phase 2
-
Phase 3
-
Submission
XENLETA® (lefamulin)
Therapeutic Area：Anti-Infective
Type：Small Molecule
Phase 1
1
1
1
1
1
1
Contepo™ (fosfomycin) for Injection
Therapeutic Area：Anti-Infective
Type：Small Molecule
Phase 1
1
1
1
1
1
1
XTMAB-16
Therapeutic Area：Immunology & Inflammation
Type：Biologic
Phase 1
1
1
1
1
1
1
-
Drug Name
-
Therapeutic Area
-
Type
-
Discovery
-
Preclinical
-
Phase 1
-
Phase 2
-
Phase 3
-
Submission
MAB-22
Oncology
Biosimilar
1
1
1
1
1
1
Filgrastim
Oncology
Biosimilar
1
1
1
1
1
1
Pegfilgrastim
Oncology
Biosimilar
1
1
1
1
1
1
Follitropin alpha (FSH)
Fertility
Biosimilar
1
1
1
1
1
1
Insulin Aspart
Diabetes
Biosimilar
1
1
1
1
1
1
Insulin Glargine
Diabetes
Biosimilar
1
1
1
1
1
1
Insulin Lispro
Diabetes
Biosimilar
1
1
1
1
1
1
-
Discovery
-
Preclinical
-
Phase 1
-
Phase 2
-
Phase 3
-
Submission
MAB-22
Therapeutic Area：Oncology
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Filgrastim
Therapeutic Area：Oncology
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Pegfilgrastim
Therapeutic Area：Oncology
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Follitropin alpha (FSH)
Therapeutic Area：Fertility
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Insulin Aspart
Therapeutic Area：Diabetes
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Insulin Glargine
Therapeutic Area：Diabetes
Type：Biosimilar
Phase 1
1
1
1
1
1
1
Insulin Lispro
Therapeutic Area：Diabetes
Type：Biosimilar
Phase 1
1
1
1
1
1
1
